Cizzle Biotechnology Holdings PLC
CIZ
Company Profile
Business description
Cizzle Biotechnology Holdings PLC is a cancer diagnostics company. It is engaged in development of test for the early detection of lung cancer via the development of an immunoassay test for the CIZ1B biomarker.
Contact
6 th floor, 60 Gracechurch Street
LondonEC3V 0HR
GBRT: +44 2039346630
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
2
Stocks News & Analysis
stocks
Fair value downgraded for ASX heavyweight
Our capital allocation rating was also lowered due to balance sheet weakness.
stocks
ChatGPT enters the retail space and one company surges
Investors cheer the ability to purchase directly from ChatGPT.
stocks
Alibaba fair value increases by 49%
Stronger-than-expected AI demand internationally and domestically.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,136.60 | 15.10 | 0.17% |
CAC 40 | 7,923.52 | 27.58 | 0.35% |
DAX 40 | 23,977.72 | 97.00 | 0.41% |
Dow JONES (US) | 46,397.89 | 81.82 | 0.18% |
FTSE 100 | 9,416.06 | 65.63 | 0.70% |
HKSE | 26,855.56 | 232.68 | 0.87% |
NASDAQ | 22,660.01 | 68.86 | 0.30% |
Nikkei 225 | 44,550.85 | 381.78 | -0.85% |
NZX 50 Index | 13,433.99 | 141.63 | 1.07% |
S&P 500 | 6,688.46 | 27.25 | 0.41% |
S&P/ASX 200 | 8,845.70 | 12.30 | 0.14% |
SSE Composite Index | 3,882.78 | 20.25 | 0.52% |